Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: J Crit Care. 2016 Jun 23;36:18–23. doi: 10.1016/j.jcrc.2016.06.012

Figure 2.

Figure 2

Adjusted probability of 30-day mortality according to the plasma neuron specific enolase (NSE) concentration at intensive care unit admission. Points represent the adjusted mortality risk and vertical error bars represent 95% confidence intervals. The NSE concentration is plotted on the log base 2 scale. After adjustment for Acute Physiology and Chronic Health Evaluation III score, admission location, race, and acute respiratory distress syndrome each two-fold increase in the plasma NSE concentration was associated with a 7.3% increased risk of 30-day mortality (p=0.003).